Sanjivani Paranteral Reports Mixed Financial Results Amid Growth and Profitability Challenges in August 2025

Sanjivani Paranteral, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 12, 2025, indicate a mixed performance landscape for the company. On a positive note, Sanjivani Paranteral's net sales for the latest six months reached Rs 36.07 crore, reflecting a year-on-year growth of 23.11%. Additionally, the profit after tax (PAT) for the nine-month period stood at Rs 5.82 crore, showcasing a year-on-year increase of 25.97%. These figures suggest a favorable near-term sales and profitability trend. Conversely, the company faced challenges as well. The earnings per share (EPS) for the quarter hit a low of Rs 1.46, marking the lowest level in the past five quarters, indicating a decline in profitability for shareholders. Furthermore, the debtors turnover ratio was recorded at 4.20 times, the lowest in the last five half-yearly periods, suggesting a slowdown in the company's ability to settle its debts. In light of these developments, there has been an adjustment in evaluation for Sanjivani Paranteral. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.